Clinical Trial Update: A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients [Phase 2]

View source ↗

Summary

A Phase 2 study comparing tolerability of etravirine to efavirenz, each with two nucleoside/nucleotide reverse transcriptase inhibitors, in treatment-naive HIV-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Intelence (Etravirine)
• Sustiva (efavirenz)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: HIV Infection, HIV | Phase 2 | Status: COMPLETED | Results posted: 2011-03-07